Ember Therapeutics, Inc. (OTCPK:EMBT) entered into an asset purchase agreement to acquire the assets of Dermasilk Brands, Inc. from Midwood Distributors, Inc. for $1.3 million in stock on September 8, 2016. Ember Therapeutics issue 2.1 million shares as a consideration for the transaction. As part of the transaction, all assets from Dermasilk Brands, Inc. will be transferred to Ember Therapeutics, Inc. Any willful, capricious or other inexcusable default hereunder on the part of either party shall entitle the aggrieved party to the sum of $2 million as liquidated damages for breach of this contract in addition to repayment in full of any sum paid hereunder as aforesaid, said amount being hereby agreed upon by reason of the difficulty in reducing the exact damages actually sustained to a mathematical certainty. Inbar Group, Inc. acted as broker for Midwood Distributors. Midwood Distributors will pay Inbar Group a commission at the rate of 10% of the consideration paid. Ember Therapeutics, Inc. (OTCPK:EMBT) completed the acquisition of the assets of Dermasilk Brands, Inc. from Midwood Distributors, Inc. on September 8, 2016.